CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: June 27, 2005
Result type: Reports
Project Number: SR0036-000
Product Line: Reimbursement Review

Generic Name: Pregabalin

Brand Name: Lyrica

Manufacturer: Pfizer Canada Inc.

Therapeutic Area: Pain, Neuropathic

Indications: Pain, Neuropathic

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: January 25, 2006

Recommendation Type: Do not list